Cost-effectiveness of three different vaccination strategies against measles in Zambian children.

نویسندگان

  • Gustavo H Dayan
  • Lisa Cairns
  • Nalinee Sangrujee
  • Anne Mtonga
  • Van Nguyen
  • Peter Strebel
چکیده

The vaccination program in Zambia includes one dose of measles vaccine at 9 months of age. The objective of this study was to compare the cost-effectiveness of the current one-dose measles vaccination program with an immunization schedule in which a second dose is provided either through routine health services or through supplemental immunization activities (SIAs). We simulated the expected cost and impact of the vaccination strategies for an annual cohort of 400,000 children, assuming 80% vaccination coverage in both routine and SIAs and an analytic horizon of 15 years. A vaccination program which includes SIAs reaching children not previously vaccinated would prevent on additional 29,242 measles cases and 1462 deaths for each vaccinated birth cohort when compared with a one-dose program. Given the parameters established for this analysis, such a program would be cost-saving and the most cost-effective vaccination strategy for Zambia.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Cost-effectiveness of measles outbreak intervention strategies.

In this study, we compared the likely cost-effectiveness of alternative strategies for controlling a school-based measles outbreak. The analysis involved assessing the expected costs and number of cases in a school-based outbreak of measles, with no intervention and with each of six control strategies. The marginal cost per case prevented ranged from $32.90 when only previously unvaccinated sch...

متن کامل

Strategic planning for measles control: using data to inform optimal vaccination strategies.

BACKGROUND In response to repeated requests for assistance in evaluating the health benefit and cost implications of adjustments to national measles immunization strategies, the World Health Organization (WHO) has developed the Measles Strategic Planning (MSP) tool to harness routinely available data to estimate effectiveness and cost effectiveness of vaccination strategies. METHOD The MSP to...

متن کامل

مقایسه سطح آنتی بادی و تعداد واکسن MMR کودکان زیر سه سال بستری در مرکز پزشکی افضلی پور کرمان

  Received: 15 Aug, 2012 Accepted: 19 Oct, 2012  Abstract :  Background & Aims: Measles, rubella and mumps vaccination prevented the viral diseases threatening children during the recent decades. The incidences of these diseases in countries with high vaccination coverage have reduced significantly. Initial vaccination was as a single dose and then two dose vaccination was introduced. This chan...

متن کامل

Measles Sero–surveillance in Soldiers prior to Nation–wide Vaccination in Iran

Background: Measles is a contagious respiratory viral infection that accompanied with skin rash. Vaccination against measles has reduced the prevalence of the disease but sporadic measles epidemic still occurred in young people. This study, was carried out for the response evaluation of immunity against measles in Iranian soldiers living in garrisons. Methods: In this study based on the history...

متن کامل

Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study.

BACKGROUND Achieving the level of population immunity required for measles elimination may be difficult in regions of high human immunodeficiency virus type 1 (HIV-1) prevalence, because HIV-1-infected children may be less likely to respond to or maintain protective antibody levels after vaccination. METHODS We conducted a prospective study of the immunogenicity of standard-titer measles vacc...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Vaccine

دوره 22 3-4  شماره 

صفحات  -

تاریخ انتشار 2004